B Background
• Hypofractionated (HF) radiation therapy (RT), which is a shorter course of RT with a larger dose at each treatment, was found to be similar in disease free survival compared to longer course of RT.
• In 1092 analyzable men with low-risk PrCa, 70 Gy in 28 fxs over 5.6 wks is n noninferior to 73.8 Gy in 41 fxs over 8.2 wks (DFS HR=0.85, 95% CI: 0.64, 1.14)
• However, there was some concern that HF arm had slight increase over the conventional fraction (CF) arm in late grade 2 (mild) clinician reported adverse events
• GI adverse events HF arm 18% vs CF arm 11% p=0.002 • GU adverse events HF arm 26% vs CF arm 20.5% p=0.06 WR Lee et al ASTRO plenary 2015
• The purpose of this study was to assess difference in patient reported outcomes between arms Expanded Prostate Index Composite (EPIC) used to measure health related quality of life and symptoms
• 50 item patient reported outcomes (PRO) questionnaire measured on a Likert scale (e.g. 0-no problem up to 4-big problem):
• Responses transformed to 0-100 • Higher scores indicating better HRQoL
• EPIC has 4 domains:
• Measured at baseline, 6 and 12 months M Method R Results: EPIC PRO at 1 year
• Hormonal scores had no change from baseline in either arm
• Sexual function had a large similar decline on both arms of about 15 points on the CF arm and 11 points on the HF arm but these changes were not significantly different
• Urinary scores exhibited almost no decline from baseline in both arms: 0 points for CF and 2 points for HF and these changes were not significantly different between arms
• Bowel scores exhibited a small decline from baseline in both arms: 0 points for CF and 2 points for HF and these changes were not significantly different between arms
• As compared with CF, pts treated with HF had a statistically larger decline in bowel scores, however this change was not deemed clinically significant -meaning the patients could not tell the difference in bowel changes between the shorter HF arm and the longer CF arm 
